Gentaur Molecular :LCLabs \ Ridaforolimus \ R-7040

GENTAUR Belgium BVBA BE0473327336 Voortstraat 49, 1910 Kampenhout BELGIUM Tel 0032 16 58 90 45
GENTAUR U.S.A Genprice Inc 6017 Snell Ave, Ste 357, SanJose, CA 95123
Tel (408) 780-0908, Fax (408) 780-0908, sales@genprice.com

Index / LCLabs / Ridaforolimus / Product Detail : R-7040 Ridaforolimus
Related keywords:

Save

Aug
19th

#R-7040 Ridaforolimus

Ask technical file .

Price :	642	EUR
	728	USD
	498	GBP
	2696	Zloty
	85883	JPY
	4950	NOK
	5304	SEK
	726	CHF

Product name : Ridaforolimus

Catalog number : R-7040

Quantity: 200 mg

Availability: Yes

Supplier name : LCLabs

Data sheet: Ask more or other datasheet now !

Order this product by Fax : Amount

Contact us about this product :

Our team will respond you as soon as possible !

List !

We have also other products like : Ridaforolimus

Related products : Ridaforolimus

Gentaurpub

Pathways :
No related Items
Related Genes :

Bibliography :
[28136820] Pulmonary complications with the use of mTOR inhibitors in targeted cancer therapy: A systematic review and meta-analysis.
[28136744] Metabolic complications with the use of mTOR inhibitors for cancer therapy: A systematic review and meta-analysis.
[28794001] Randomized Comparison of Ridaforolimus-Eluting and Zotarolimus-Eluting Coronary Stents in Patients with Coronary Artery Disease: Primary Results from the BIONICS Trial.
[28681171] A randomized phase II trial of ridaforolimus, dalotuzumab, and exemestane compared with ridaforolimus and exemestane in patients with advanced breast cancer.
[28595616] Phase I study of oral ridaforolimus in combination with paclitaxel and carboplatin in patients with solid tumor cancers.
[28324268] A phase II study of combined ridaforolimus and dalotuzumab compared with exemestane in patients with estrogen receptor-positive breast cancer.
[28146265] m-TOR inhibitors and their potential role in haematological malignancies.
[27931828] Targeting mTOR pathway in gynecological malignancies: Biological rationale and systematic review of published data.
[27793898] Targeting the PI3K/PTEN/AKT/mTOR Pathway in Treatment of Sarcoma Cell Lines.
[27765027] Ridaforolimus (MK-8669) synergizes with Dalotuzumab (MK-0646) in hormone-sensitive breast cancer.

Search in Google:

Share this page:

Quick order!
Enter catalog number :

Categories :

Multiplex Cytokine Assays

Gentaur; yes we can

Favorites Pages:
No Favorits

More Del

Email :
Skype :
Name :
Phone :
address :
Question, Comment ... :
Please retype this code below: $LCLabs \ Ridaforolimus \ R_7040$

GENTAUR Molecular Products.

#R-7040 Ridaforolimus

Contact us about this product :

We have also other products like : Ridaforolimus